0001645113-22-000021.txt : 20220307 0001645113-22-000021.hdr.sgml : 20220307 20220307182521 ACCESSION NUMBER: 0001645113-22-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220303 FILED AS OF DATE: 20220307 DATE AS OF CHANGE: 20220307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weinberg Uri CENTRAL INDEX KEY: 0001811030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 22719708 MAIL ADDRESS: STREET 1: NOVOCURE INC., 20 VALLEY STREAM PARKWAY STREET 2: SUITE 300 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_164669550591279.xml FORM 4 X0306 4 2022-03-03 0 0001645113 NovoCure Ltd NVCR 0001811030 Weinberg Uri C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Science Officer Ordinary Shares 2022-03-03 4 A 0 17371 0 A 49186 D Options to Buy Ordinary Shares 80.59 2022-03-03 4 A 0 30422 80.59 A 2023-03-01 2032-02-29 Ordinary Shares 30422.0 30422 D Options to Buy Ordinary Shares 80.59 2022-03-03 4 A 0 4961 80.59 A 2023-03-01 2032-02-29 Ordinary Shares 4961.0 4961 D Represents restricted share units that are scheduled to vest on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates. Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates. Options to buy 4,961 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates. By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg 2022-03-07